APA

Gaken J. A., Hollingsworth S. J., Hirst W. J., Buggins A. G., Galea-Lauri J., Peakman M., Kuiper M., Patel P., Towner P., Patel P. M., Collins M. K., Mufti G. J., Farzaneh F. & Darling D. C. (19970508). Irradiated NC adenocarcinoma cells transduced with both B7.1 and interleukin-2 induce CD4+-mediated rejection of established tumors. : Human gene therapy.

Chicago

Gaken J A, Hollingsworth S J, Hirst W J, Buggins A G, Galea-Lauri J, Peakman M, Kuiper M, Patel P, Towner P, Patel P M, Collins M K, Mufti G J, Farzaneh F and Darling D C. 19970508. Irradiated NC adenocarcinoma cells transduced with both B7.1 and interleukin-2 induce CD4+-mediated rejection of established tumors. : Human gene therapy.

Harvard

Gaken J. A., Hollingsworth S. J., Hirst W. J., Buggins A. G., Galea-Lauri J., Peakman M., Kuiper M., Patel P., Towner P., Patel P. M., Collins M. K., Mufti G. J., Farzaneh F. and Darling D. C. (19970508). Irradiated NC adenocarcinoma cells transduced with both B7.1 and interleukin-2 induce CD4+-mediated rejection of established tumors. : Human gene therapy.

MLA

Gaken J A, Hollingsworth S J, Hirst W J, Buggins A G, Galea-Lauri J, Peakman M, Kuiper M, Patel P, Towner P, Patel P M, Collins M K, Mufti G J, Farzaneh F and Darling D C. Irradiated NC adenocarcinoma cells transduced with both B7.1 and interleukin-2 induce CD4+-mediated rejection of established tumors. : Human gene therapy. 19970508.